Endo International plc has received an extension of its exclusive U.S. marketing rights for Voltaren Gel (diclofenac sodium topical gel 1%), a nonsteriodal anti-inflammatory drug (NSAID). Endo said Monday that it also was granted extended U.S.
Horizon Pharma plc plans to acquire Crealta Holdings LLC for $510 million in cash. Horizon said the deal will bring the company Krystexxa (pegloticase), the first and only Food and Drug Administration-approved drug for chronic refractory gout.
Takeda Pharmaceutical Co. has released Ninlaro capsules (ixazomib), a blood cancer medication, in the United States. Takeda said Friday that Ninlaro is the first and only oral proteasome inhibitor.
In tandem with a congressional hearing, the National Community Pharmacists Association called on lawmakers to take a closer look at recent generic drug price hikes and their impact on patients and community pharmacists.
Amneal Pharmaceuticals LLC has begun shipping lidocaine 5% ointment to lead off the launch of a new lidocaine product line. Amneal said late Tuesday that its lidocaine 5% ointment is available in a 35.44-g tube with child-resistant cap and in a 50-g jar.
Camber Pharmaceuticals has released fluoxetine capsules, an antidepressant, and losartan potassium, a hypertension medication. Camber said Tuesday that its fluoxetine capsules are available in strengths of 10 mg, 20 mg, 40 mg in both 30 and 100-count bottles.
With its recent acquisitions, Rite Aid Corp. is well-positioned to further expand its health care capabilities, according to chairman and chief executive officer John Standley.
UnitedHealth Group Inc. may pull out of Affordable Care Act health insurance exchanges in 2017 after losing what it said were hundreds of millions of dollars on policies sold under the law.
Health care spending in the United States last year exceeded $3 trillion as five years of slow growth was replaced by the Affordable Care Act’s expansion of Medicaid and private health insurance coverage. Prescription drug prices accelerated as well.
Despite widespread criticism over the issue of tax inversions, legal experts say that current regulatory restrictions in the United States are unlikely to block the $160 billion merger deal announced by U.S. pharmaceutical giant Pfizer and Ireland-based drug manufacturer Allergan Inc.
The National Association of Chain Drug Stores made its voice heard this week on two key pharmacy matters: importation of prescription drugs and prescription refill reminders.
Heritage Pharmaceuticals Inc. has rolled verapamil 40-mg immediate-release tablets, a calcium channel blocker medication. Heritage said that its verapamil product is a generic version of Pfizer Inc.’s Calan, indicated for the treatment of angina, arrhythmias and hypertension.
Walgreens has enhanced its flu tracker tool to provide more specific location information. The drug chain said it has launched the first weekly Walgreens Flu Index for the 2015-16 season.
Rite Aid Corp. has begun offering discounts on certain trivalent flu shots in support of National Influenza Vaccination Week. Rite Aid said Wednesday that through Dec. 12 it will provide the cell-based flu vaccine Flucelvax for $32.99 and the standard trivalent flu shot for $26.99, a discount of $5.
When given a choice in purchasing a prescription or over-the-counter drug, most U.S. consumers will opt for a generic product, a new Harris Poll finds. Harris said Wednesday that of the 2,255 U.S.
Publix Super Markets Inc. has expanded supply options in its free medication program to help patients on maintenance medicines.
